{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T08:28:57Z","timestamp":1769329737756,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lyme borreliosis is the most prevalent arthropod-borne infection in the Northern Hemisphere. In Europe, <jats:italic>Borrelia\u00a0afzelii<\/jats:italic> is predominantly involved in cutaneous manifestations, <jats:italic>Borrelia<\/jats:italic>\u00a0<jats:italic>garinii<\/jats:italic> and <jats:italic>Borrelia bavariensis<\/jats:italic> in neurological manifestations, and <jats:italic>Borrelia<\/jats:italic>\u00a0<jats:italic>burgdorferi<\/jats:italic> sensu stricto in articular ones. Liver impairement is not classical in Lyme borreliosis. Diagnosis is currently mainly based on serological testing, and is challenging in immunocompromised patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the first case of <jats:italic>B.\u00a0garinii<\/jats:italic> infection revealed by liver involvement in an immunocompromised man. A 73-year-old man with marginal zone lymphoma, treated with bendamustine and rituximab, developed intermittent fever and inflammatory syndrome. Microbial investigations were all negative and FDG-PET showed complete remission of the lymphoma. Three months later, liver biopsy was performed and histology revealed spirochetes-like bacteria. Microbial diagnosis was performed by 16S rDNA sequencing, flagellin (<jats:italic>fla<\/jats:italic>B) gene sequencing and multi-locus sequence typing and identified <jats:italic>B.\u00a0garinii<\/jats:italic>. The patient recovered successfully after a three weeks course of antibiotics. Diagnosis was challenging because <jats:italic>Borrelia<\/jats:italic> hepatic involvement is unusual and no <jats:italic>erythema migrans<\/jats:italic> nor tick bite were notified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case highlights that unexplained fever and inflammatory syndrome in immunocompromised patients warrants specific investigations to identify bacteria such as spirochetes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12941-022-00506-6","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T11:02:44Z","timestamp":1648465364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["An unexpected case of Borrelia garinii liver infection"],"prefix":"10.1186","volume":"21","author":[{"given":"Pierre","family":"Duffau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skander","family":"Korbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Guillotin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Talagrand-Reboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armelle","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Peuchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,27]]},"reference":[{"issue":"1","key":"506_CR1","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1186\/s12889-021-11850-1","volume":"21","author":"A Septfons","year":"2021","unstructured":"Septfons A, Figoni J, Gautier A, Soullier N, de Valk H, Desenclos JC. Increased awareness and knowledge of Lyme Borreliosis and tick bite prevention among the general population in France: 2016 and 2019 health barometer survey. BMC Public Health. 2021;21(1):1808.","journal-title":"BMC Public Health"},{"issue":"1","key":"506_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","volume":"17","author":"G Stanek","year":"2011","unstructured":"Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. ClinMicrobiol Infect. 2011;17(1):69\u201379.","journal-title":"ClinMicrobiol Infect"},{"issue":"9814","key":"506_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461\u201373.","journal-title":"Lancet"},{"issue":"5","key":"506_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.medmal.2019.04.381","volume":"49","author":"J Figoni","year":"2019","unstructured":"Figoni J, Chirouze C, Hansmann Y, Lemogne C, Hentgen V, Saunier A, et al. Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis. Med Mal Infect. 2019;49(5):318\u201334.","journal-title":"Med Mal Infect"},{"key":"506_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4939-7383-5_2","volume":"1690","author":"G Margos","year":"2018","unstructured":"Margos G, Notter I, Fingerle V. Species identification and phylogenetic analysis of Borrelia burgdorferi sensu lato using molecular biological methods. Methods Mol Biol. 2018;1690:13\u201333.","journal-title":"Methods Mol Biol"},{"issue":"8559","key":"506_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(87)93009-1","volume":"2","author":"P Chavanet","year":"1987","unstructured":"Chavanet P, Pillon D, Lancon JP, Waldner-Combernoux A, Maringe E, Portier H. Granulomatous hepatitis associated with Lyme disease. Lancet. 1987;2(8559):623\u20134.","journal-title":"Lancet"},{"issue":"2","key":"506_CR7","first-page":"193","volume":"25","author":"I Dadamessi","year":"2001","unstructured":"Dadamessi I, Brazier F, Smail A, Delcenserie R, Dupas JL, Capron JP. Hepatic disorders related to Lyme disease Study of two cases and a review of the literature. Gastroenterol Clin Biol. 2001;25(2):193\u20136.","journal-title":"Gastroenterol Clin Biol"},{"issue":"5","key":"506_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.7326\/0003-4819-108-5-707","volume":"108","author":"MH Goellner","year":"1988","unstructured":"Goellner MH, Agger WA, Burgess JH, Duray PH. Hepatitis due to recurrent Lyme disease. Ann Intern Med. 1988;108(5):707\u20138.","journal-title":"Ann Intern Med"},{"issue":"10","key":"506_CR9","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s10620-006-9405-9","volume":"52","author":"AC Zanchi","year":"2007","unstructured":"Zanchi AC, Gingold AR, Theise ND, Min AD. Necrotizing granulomatous hepatitis as an unusual manifestation of Lyme disease. Dig Dis Sci. 2007;52(10):2629\u201332.","journal-title":"Dig Dis Sci"},{"key":"506_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.13070\/rs.en.1.875","volume":"1","author":"MJ Middelveen","year":"2014","unstructured":"Middelveen MJ, McClain SA, Bandoski C, Israel JR, Burke J, MacDonald AB, et al. Granulomatous hepatitis associated with chronic Borrelia burgdorferi infection: a case report. Research. 2014;1:875. https:\/\/doi.org\/10.13070\/rs.en.1.875.","journal-title":"Research"},{"issue":"12","key":"506_CR11","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1086\/648091","volume":"200","author":"K Strle","year":"2009","unstructured":"Strle K, Drouin EE, Shen S, El Khoury J, McHugh G, Ruzic-Sabljic E, et al. Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii. J Infect Dis. 2009;200(12):1936\u201343.","journal-title":"J Infect Dis"},{"issue":"2","key":"506_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"AC Steere","year":"2001","unstructured":"Steere AC. Lyme disease. N Engl J Med. 2001;345(2):115\u201325.","journal-title":"N Engl J Med"},{"issue":"26","key":"506_CR13","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1056\/NEJMcp061181","volume":"354","author":"GP Wormser","year":"2006","unstructured":"Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med. 2006;354(26):2794\u2013801.","journal-title":"N Engl J Med"},{"issue":"1","key":"506_CR14","first-page":"76","volume":"99","author":"AC Steere","year":"1983","unstructured":"Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, et al. The early clinical manifestations of Lyme disease. AnnInternMed. 1983;99(1):76\u201382.","journal-title":"AnnInternMed"},{"issue":"4","key":"506_CR15","first-page":"409","volume":"2","author":"MA Kazakoff","year":"1993","unstructured":"Kazakoff MA, Sinusas K, Macchia C. Liver function test abnormalities in early Lyme disease. Arch FamMed. 1993;2(4):409\u201313.","journal-title":"Arch FamMed"},{"issue":"6","key":"506_CR16","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/hep.510230617","volume":"23","author":"HW Horowitz","year":"1996","unstructured":"Horowitz HW, Dworkin B, Forseter G, Nadelman RB, Connolly C, Luciano BB, et al. Liver function in early Lyme disease. Hepatology. 1996;23(6):1412\u20137.","journal-title":"Hepatology"},{"issue":"5","key":"506_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.medmal.2019.05.001","volume":"49","author":"B Jaulhac","year":"2019","unstructured":"Jaulhac B, Saunier A, Caumes E, Bouiller K, Gehanno JF, Rabaud C, et al. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis. Med Mal Infect. 2019;49(5):335\u201346.","journal-title":"Med Mal Infect"},{"issue":"1","key":"506_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12879-018-3273-8","volume":"18","author":"A Wagemakers","year":"2018","unstructured":"Wagemakers A, Visser MC, de Wever B, Hovius JW, van de Donk N, Hendriks EJ, et al. Case report: persistently seronegative neuroborreliosis in an immunocompromised patient. BMC Infect Dis. 2018;18(1):362.","journal-title":"BMC Infect Dis"},{"key":"506_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00018-19","author":"JA Branda","year":"2021","unstructured":"Branda JA, Steere AC. Laboratory diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2021. https:\/\/doi.org\/10.1128\/CMR.00018-19.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"506_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10408363.2018.1450353","volume":"55","author":"B Lohr","year":"2018","unstructured":"Lohr B, Fingerle V, Norris DE, Hunfeld KP. Laboratory diagnosis of Lyme borreliosis: current state of the art and future perspectives. CritRev Clin Lab Sci. 2018;55(4):219\u201345.","journal-title":"CritRev Clin Lab Sci"},{"issue":"3","key":"506_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/mec.15336","volume":"29","author":"AC Norte","year":"2020","unstructured":"Norte AC, Margos G, Becker NS, Albino Ramos J, Nuncio MS, Fingerle V, et al. Host dispersal shapes the population structure of a tick-borne bacterial pathogen. Mol Ecol. 2020;29(3):485\u2013501.","journal-title":"Mol Ecol"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-022-00506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-022-00506-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-022-00506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T11:04:55Z","timestamp":1648465495000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-022-00506-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,27]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1186\/s12941-022-00506-6","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,27]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. According to the French legislation, Ethical approval for a single case is not required, as long as the data kept anonymous, and the investigations do not imply human genetic results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish this paper was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}